I think you’ll agree with me that this new recommendation has been worth the wait. BioTime, Inc (Nasdaq: BTIM) is revolutionizing stem cell research.

The company literally turns back the clock on adult cells and turns them into embryonic stem cells. As you can imagine, the potential for this technology is endless.

The exciting details are in this report .

IMGN Results After the Close

After the market closes this afternoon, Immunogen (Nasdaq: IMGN) will report fiscal second quarter results. Wall Street expects a loss of 21 cents on revenue of $4.33 million.

As I’ve stated before, at this stage, the financial results are not as important as any updates on the company’s pipeline. Considering that I just saw CEO Daniel Junius in San Francisco a few weeks ago, I’m not expecting any significant news. However, I’ll be on the conference call just in case, and I’ll update you tomorrow morning if there are any important developments.

In the meantime, we’ll anxiously wait for data on T-DM1 and partnerships on other drugs in the pipeline.

Marc Lichtenfeld
Director of Research
Access Research Group

---

Current Portfolio:

Name: Delcath Systems
Symbol: DCTH
Current Price: $4.60
Comments: Buy up to $7.00

Name: ATS Medical
Symbol: ATSI
Current Price: $2.67
Comments: Buy up to $3.30. Sell stop is $2.40.

Name: Rochester Medical
Symbol: ROCM
Current Price: $12.61
Comments: Buy up to $15.00. Sell stop is $8.88.

Name: Cytori Therapeutics
Symbol: CYTX
Current Price: $8.03
Comments: Buy up to $5.00. Sell stop is $6.16.

Name: Electro-Optical Sciences
Symbol: MELA
Current Price: $9.30
Comments: HOLD. Sell stop is $8.33.

Name: Immunogen
Symbol: IMGN
Current Price: $7.36
Comments: Buy up to $8.50.

Name: SciClone Pharmaceuticals
Symbol: SCLN
Current Price: $2.64
Comments: Buy up to $3.50. Sell stop is $1.86.

Name: Synovis Life Technologies
Symbol: SYNO
Current Price: $13.30
Comments: Buy up to $15.00. Sell stop is $10.34.

Name: Celldex Technologies
Symbol: CLDX
Current Price: $4.47
Comments: Buy up to $6.50